Baird analyst Michael Halloran maintains $IDEX Corp (IEX.US)$ with a buy rating, and maintains the target price at $241.
According to TipRanks data, the analyst has a success rate of 61.1% and a total average return of 11.1% over the past year.
Furthermore, according to the comprehensive report, the opinions of $IDEX Corp (IEX.US)$'s main analysts recently are as follows:
The company reported a modest increase in operating income and raised the lower end of its future guidance. A notable positive aspect was the stabilization in the life sciences area of the Health & Science Technologies segment, which had previously experienced an extended period of destocking and general underperformance.
The firm noted that 3Q results for Idex Corp. were operationally consistent, with upside in FSDP counterbalancing downside in FMT. The company's guidance for 2024 was improved at the lower end, and the projections for 4Q are in line with consensus. The firm found the stabilization in daily order rates, demand commentary, and estimates to be a positive sign, especially after a challenging period for the company.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
貝雅分析師Michael Halloran維持$IDEX Corp (IEX.US)$買入評級，維持目標價241美元。
根據TipRanks數據顯示，該分析師近一年總勝率為61.1%，總平均回報率為11.1%。
此外，綜合報道，$IDEX Corp (IEX.US)$近期主要分析師觀點如下：
該公司報告營業收入略有增長，並提高了未來預期的下限。一個值得注意的積極方面是健康與科學技術板塊的生命科學領域的穩定，該板塊此前曾經歷過長時間的去庫存，表現普遍不佳。
該公司指出，Idex Corp. 第三季度業績保持穩定，FSDP的上行抵消了fMT的下行空間。該公司對2024年的低端預期有所改善，對第四季度的預測符合共識。該公司發現，每日訂單率、需求評論和估計的穩定是一個積極的信號，尤其是在公司經歷了艱難的時期之後。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
